Fund profile
Tickers
FPHAX
Fund manager
Total assets
$1.11 bn
Liabilities
$30.98 mm
Net assets
$1.08 bn
Number of holdings
70.00
70 Holdings
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
LLY Lilly(Eli) & Co | 256.30 mm | 340.06 k shares | 23.81 | Common equity | Long | USA |
NVO Novo Nordisk | 155.19 mm | 1.30 mm shares | 14.41 | Common equity | Long | Denmark |
ASTRAZENECA PLC SPONS ADR
|
88.66 mm | 1.38 mm shares | 8.23 | Common equity | Long | UK |
GSK GSK Plc | 52.40 mm | 1.25 mm shares | 4.87 | Common equity | Long | UK |
MRK Merck & Co Inc | 51.67 mm | 406.34 k shares | 4.80 | Common equity | Long | USA |
UCB SA
|
41.69 mm | 362.20 k shares | 3.87 | Common equity | Long | Belgium |
ROYALTY PHARMA PLC
|
33.74 mm | 1.11 mm shares | 3.13 | Common equity | Long | UK |
GILD Gilead Sciences, Inc. | 32.55 mm | 451.50 k shares | 3.02 | Common equity | Long | USA |
Fidelity Securities Lending Cash Central Fund | 29.69 mm | 29.69 mm shares | 2.76 | Short-term investment vehicle | Long | USA |
MRNA Moderna Inc | 27.41 mm | 297.20 k shares | 2.55 | Common equity | Long | USA |
LEGN Legend Biotech Corp | 23.97 mm | 367.90 k shares | 2.23 | Common equity | Long | Cayman Islands |
MERCK KGAA
|
21.93 mm | 128.90 k shares | 2.04 | Common equity | Long | Germany |
BPMC Blueprint Medicines Corp | 21.58 mm | 230.70 k shares | 2.00 | Common equity | Long | USA |
DYN Dyne Therapeutics Inc | 20.07 mm | 746.00 k shares | 1.86 | Common equity | Long | USA |
GERRESHEIMER AG
|
18.27 mm | 155.90 k shares | 1.70 | Common equity | Long | Germany |
SRPT Sarepta Therapeutics Inc | 15.63 mm | 122.20 k shares | 1.45 | Common equity | Long | USA |
BIIB Biogen Inc | 14.93 mm | 68.80 k shares | 1.39 | Common equity | Long | USA |
ROCHE HOLDINGS AG (GENUSSCHEINE)
|
14.60 mm | 55.86 k shares | 1.36 | Common equity | Long | Switzerland |
CTLT Catalent Inc. | 14.30 mm | 249.40 k shares | 1.33 | Common equity | Long | USA |
Fidelity Cash Central Fund | 14.13 mm | 14.13 mm shares | 1.31 | Short-term investment vehicle | Long | USA |
RNA Avidity Biosciences Inc | 11.53 mm | 630.20 k shares | 1.07 | Common equity | Long | USA |
XENE Xenon Pharmaceuticals Inc | 10.67 mm | 226.00 k shares | 0.99 | Common equity | Long | Canada |
BMY Bristol-Myers Squibb Co. | 9.62 mm | 189.48 k shares | 0.89 | Common equity | Long | USA |
EWTX Edgewise Therapeutics Inc | 7.12 mm | 436.30 k shares | 0.66 | Common equity | Long | USA |
FULC Fulcrum Therapeutics Inc | 6.98 mm | 683.60 k shares | 0.65 | Common equity | Long | USA |
INDIVIOR PLC
|
5.81 mm | 268.20 k shares | 0.54 | Common equity | Long | UK |
LUNG Pulmonx Corp | 5.66 mm | 614.30 k shares | 0.53 | Common equity | Long | USA |
NEWAMSTERDAM PHARMA COMPANY NV
|
5.57 mm | 243.70 k shares | 0.52 | Common equity | Long | Netherlands |
ASND Ascendis Pharma A/S | 5.33 mm | 36.10 k shares | 0.50 | Common equity | Long | Denmark |
BEAM Beam Therapeutics Inc | 5.32 mm | 134.70 k shares | 0.49 | Common equity | Long | USA |
MERUS B.V.
|
5.24 mm | 108.00 k shares | 0.49 | Common equity | Long | Netherlands |
GLUE Monte Rosa Therapeutics Inc | 5.04 mm | 796.40 k shares | 0.47 | Common equity | Long | USA |
RCUS Arcus Biosciences Inc | 4.68 mm | 244.40 k shares | 0.43 | Common equity | Long | USA |
LNTH Lantheus Holdings Inc | 4.62 mm | 70.60 k shares | 0.43 | Common equity | Long | USA |
NTLA Intellia Therapeutics Inc | 4.28 mm | 133.20 k shares | 0.40 | Common equity | Long | USA |
HRMY Harmony Biosciences Holdings Inc | 4.19 mm | 130.68 k shares | 0.39 | Common equity | Long | USA |
CRISPR THERAPEUTICS AG
|
4.05 mm | 48.05 k shares | 0.38 | Common equity | Long | Switzerland |
INSP Inspire Medical Systems Inc | 3.90 mm | 21.80 k shares | 0.36 | Common equity | Long | USA |
SPYRE THERAPEUTICS INC PIPE
|
3.56 mm | 136.58 k shares | 0.33 | Common equity | Long | USA |
ION BEAM APPLICATIONS SA REG
|
3.54 mm | 350.60 k shares | 0.33 | Common equity | Long | Belgium |
AXSM Axsome Therapeutics Inc | 3.53 mm | 43.40 k shares | 0.33 | Common equity | Long | USA |
AVBP ArriVent BioPharma Inc. | 3.27 mm | 151.60 k shares | 0.30 | Common equity | Long | USA |
BLUE Bluebird bio Inc | 3.09 mm | 2.23 mm shares | 0.29 | Common equity | Long | USA |
AGL Agilon Health Inc | 2.85 mm | 464.93 k shares | 0.26 | Common equity | Long | USA |
ALNY Alnylam Pharmaceuticals Inc | 2.22 mm | 14.67 k shares | 0.21 | Common equity | Long | USA |
PROTHENA CORP PLC
|
2.09 mm | 75.80 k shares | 0.19 | Common equity | Long | Ireland |
AGOMAB THERAPEUTICS SA SER C PC PP | 1.92 mm | 7.73 k shares | 0.18 | Preferred equity | Long | Belgium |
PARAGON BIOSCIENCES EMALEX CAPITAL INC SER C PC PP | 1.88 mm | 158.88 k shares | 0.17 | Preferred equity | Long | USA |
GBIO Generation Bio Co | 1.80 mm | 715.28 k shares | 0.17 | Common equity | Long | USA |
CYTK Cytokinetics Inc | 1.67 mm | 23.10 k shares | 0.15 | Common equity | Long | USA |
ANNX Annexon Inc | 1.63 mm | 291.89 k shares | 0.15 | Common equity | Long | USA |
SLRN Acelyrin Inc | 1.52 mm | 180.37 k shares | 0.14 | Common equity | Long | USA |
GPCR Structure Therapeutics Inc | 1.44 mm | 35.40 k shares | 0.13 | Common equity | Long | Cayman Islands |
CASTLE CREEK BIOSCIENCES INC SER D-1 PC PP | 1.33 mm | 6.31 k shares | 0.12 | Preferred equity | Long | USA |
GLPG Galapagos NV | 1.30 mm | 36.90 k shares | 0.12 | Common equity | Long | Belgium |
ARVN Arvinas Inc | 1.21 mm | 26.30 k shares | 0.11 | Common equity | Long | USA |
IRON Disc Medicine Inc | 1.20 mm | 17.53 k shares | 0.11 | Common equity | Long | USA |
EVOZYNE INC SER B PC PP | 969.16 k | 56.64 k shares | 0.09 | Preferred equity | Long | USA |
EVOZYNE INC CPIK 6% 09/13/2028 P/P | 958.59 k | 893.38 k principal | 0.09 | Debt | Long | USA |
NYXOAH SA
|
836.40 k | 60.94 k shares | 0.08 | Common equity | Long | Belgium |
SYRE Spyre Therapeutics Inc. | 333.67 k | 12.16 k shares | 0.03 | Common equity | Long | USA |
PARAGON BIOSCIENCES EMALEX CAPITAL INC SER D-2 PC PP | 253.09 k | 22.48 k shares | 0.02 | Preferred equity | Long | USA |
PARAGON BIOSCIENCES EMALEX CAPITAL INC SER D-1 PC PP | 170.64 k | 14.40 k shares | 0.02 | Preferred equity | Long | USA |
SANDOZ GROUP AG SPON ADR
|
154.70 k | 4.98 k shares | 0.01 | Common equity | Long | Switzerland |
EVOZYNE INC SER A PC PP | 99.71 k | 5.90 k shares | 0.01 | Preferred equity | Long | USA |
CASTLE CREEK BIOSCIENCES INC SER C PC PERP PP | 46.62 k | 200.00 shares | 0.00 | Preferred equity | Long | USA |
CASTLE CREEK BIOSCIENCES INC SER D-2 PC PP | 15.94 k | 85.00 shares | 0.00 | Preferred equity | Long | USA |
LEAP THERAPEUTICS INC WT
|
332.09 | 60.60 k shares | 0.00 | Common equity | Long | USA |
MEDAVAIL HOLDINGS INC PIPE
|
91.08 | 66.00 shares | 0.00 | Common equity | Long | USA |
AGOMAB THERAPEUTICS SA ANTI-DILUTION WT PP 10/10/2033
|
0 | 10.00 shares | 0.00 | Common equity | Long | Belgium |